MedTrace Logo

Neuro-feedback Therapy for Treating Tinnitus

NCT03773926 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-12-12

No results posted yet for this study

Summary

Neuro-feedback for treating tinnitus seem to be a promising approach to help people suffering from chronic tinnitus. The past studies on this approach suffered interindividual variability in their results. The investigators' current hypothesis is that the variability of the results is the consequences of two possible flaws: lack of appropriate patient selection and lack of support of the patient during the therapy. This study is aimed at testing these hypotheses.

Conditions

Interventions

DEVICE

Neuro-feedback therapy

The therapy consists of 10 Neuro-feedback training sessions, 2 times per week over 5 weeks.

Sponsors & Collaborators

  • University Hospital, Toulouse

    collaborator OTHER

  • Zeta Technologies

    lead INDUSTRY

Principal Investigators

  • Marie-Josée FRAYSSE · University Hospital, Toulouse

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-28
Primary Completion
2019-01-15
Completion
2019-01-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03773926 on ClinicalTrials.gov